Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.42+0.02 (+0.31%)
Close on Nov 13, 2026Market cap $243.02MP/E –Yield –
Lifecore Biomedical enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lifecore Biomedical's enterprise value was $224.99M on Nov 11, 2026, against $278.08M a year earlier. Over the last 5 years it ranged from $121.47M to $464.97M, with a median of $288.53M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $224.99M | -22.0% |
| 2025 | Dec 31, 2025 | $288.57M | -12.7% |
| 2024 | Dec 31, 2024 | $330.37M | +22.9% |
| 2023 | Dec 29, 2023 | $268.71M | -6.1% |
| 2022 | Dec 30, 2022 | $286.11M | -36.4% |
| 2021 | Dec 31, 2021 | $449.92M | +6.7% |
| 2020 | Dec 31, 2020 | $421.78M | -0.1% |
| 2019 | Dec 31, 2019 | $422.19M | +14.6% |
| 2018 | Dec 31, 2018 | $368.25M | -4.6% |
| 2017 | Dec 29, 2017 | $385.94M | -8.3% |
| 2016 | Dec 30, 2016 | $420.95M | +18.6% |
| 2015 | Dec 31, 2015 | $354.80M | -12.2% |
| 2014 | Dec 31, 2014 | $404.00M | +15.0% |
| 2013 | Dec 31, 2013 | $351.43M | +24.8% |
| 2012 | Dec 31, 2012 | $281.56M | +121.6% |
| 2011 | Dec 30, 2011 | $127.08M | – |
| 2010 | Dec 31, 2010 | -$27.66M | – |
See a number that looks wrong?